ImmunityBio said it intends to submit a Biologic License Application for the indication of reversal of lymphopenia in patients receiving standard-of-care chemotherapy and/or radiation and for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback